Non-alcoholic fatty liver disease (NAFLD) has become the most common liver disease in
Western countries. The more severe form of this condition, non-alcoholic steatohepatitis …

Nonalcoholic fatty liver disease consists of a range of disorders characterized by excess
accumulation of triglyceride within the liver. Whereas simple steatosis is clinically benign …

Non-alcoholic steatohepatitis (NASH) is considered the advanced stage of non-alcoholic
fatty liver disease (NAFLD). It is characterized by liver steatosis, inflammation and different …

Non-alcoholic fatty liver disease (NAFLD) is emerging as one of the most common chronic
liver diseases in developed western countries. Non-alcoholic steatohepatitis (NASH) is the …

Cirrhosis has become the major liver-related clinical endpoint in non-alcoholic
steatohepatitis (NASH). However, progression to cirrhosis is less predictable in NASH than …

Liver fibrosis is the excessive expression and accumulation of extracellular matrix proteins in
the liver. Fibrotic scarring occurs as the consequence of chronic injury and inflammation …

Liver fibrosis is a multifaceted process that occurs as a consequence of chronic liver injury.
This process is characterized by inflammation, activation of matrix-producing cells, matrix …

Mechanisms of liver fibrosis are complex and varied. Among them, metabolic factors are
particularly important in the development of fibrosis associated with nonalcoholic …

Nonalcoholic steatohepatitis includes a wide spectrum of liver injury, ranging from simple
inflammation to fibrosis and cirrhosis. Whereas simple steatosis has a benign clinical …

Nonalcoholic fatty liver disease is the most prevalent liver disease worldwide, affecting 20%–
25% of the adult population. In 25% of patients, nonalcoholic fatty liver disease progresses …